Morepen Laboratories reports gross revenue of Rs 427cr in Q4 FY 2023-24
Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), a prominent figure in the Medical Devices and Active Pharmaceutical Ingredients (API) sectors, has announced stellar financial results ... Read More
Morepen Laboratories secures FDA approval for Fexofinadine (Allegra)
Morepen Laboratories Limited has secured approval from the US Food and Drug Administration (FDA) for its anti-allergy drug Fexofinadine Hydrochloride, which it expects to begin ... Read More
Morepen Laboratories spins out medical devices business
Morepen Laboratories Limited said that it has separated its point of care (POC) medical devices business into a newly formed fully-owned subsidiary called Morepen Devices ... Read More
Morepen Laboratories produces test batch of Sputnik V Covid vaccine
Morepen Laboratories and the Russian Direct Investment Fund (RDIF) announced the production of the test batch of the Russian Sputnik V Covid vaccine in an ... Read More